Darnitsa Implementing Artwork Management Solution International System for Pharmaceutical Packaging Quality Control

Darnitsa Pharmaceutical Company is the first among Ukrainian pharmaceutical companies to implement Artwork Management Solution with the integrated Verify Proofreading system by Global Vision. This system checks packaging and package leaflets for medicines and can ensure their correctness

The system is designed to reduce the risk of complaints and recalls of medicines due to errors in the labeling and packaging, as well as to ensure compliance of labeling and packaging in all markets where products are sold.

Artwork Management Solution replaces some time-consuming manual inspections, so a company implementing such system can bring products to market faster without compromising quality. Proofreading time is reduced by half with the help of digital inspections throughout the workflow.

The tool ensures uninterrupted inspections of all components: packaging, labels, leaflets, instructions, promotional materials, etc.

“Darnitsa, as one of the leaders of the pharmaceutical industry of Ukraine, understands its responsibility to consumers for the correctness of packaging and instructions for medicines. After all, every mistake in our industry without exaggeration can be truly dangerous to health and life. That is why we are the first among Ukrainian pharmaceutical companies to implement Artwork Management Solution with the integrated Verify Proofreading system by Global Vision, which guarantees the correct packaging and instructions for our medicinal products,” Oleksandr Torhun, Regulatory Affairs Director of Darnitsa Pharmaceutical Company, said.

Background information.

Darnitsa Pharmaceutical Company PrJSC was established in 1930. Since 1998, Darnitsa has been a leader in Ukraine in terms of production of medicinal products by volume. Darnitsa’s products are exported to 15 countries around the world. The company's mission is to help healthcare professionals and patients to improve their quality of life through science, innovation and accessibility. The beneficiaries of the company are the Zagoriy family.